Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Francesco P. Schena"'
Autor:
Yukako Ohyama, Hisateru Yamaguchi, Soshiro Ogata, Samantha Chiurlia, Sharon N. Cox, Nikoletta-Maria Kouri, Maria J. Stangou, Kazuki Nakajima, Hiroki Hayashi, Daijo Inaguma, Midori Hasegawa, Yukio Yuzawa, Naotake Tsuboi, Matthew B. Renfrow, Jan Novak, Aikaterini A. Papagianni, Francesco P. Schena, Kazuo Takahashi
Publikováno v:
iScience, Vol 25, Iss 11, Pp 105223- (2022)
Summary: Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 h
Externí odkaz:
https://doaj.org/article/0e848deb8d334edc9b1c8248e9c98c83
Autor:
Giorgia Schena, Monica Carmosino, Samantha Chiurlia, Laura Onuchic, Mauro Mastropasqua, Eugenio Maiorano, Francesco P. Schena, Michael J. Caplan
Publikováno v:
Physiological Reports, Vol 9, Iss 20, Pp n/a-n/a (2021)
Abstract Autosomal dominant polycystic kidney disease (ADPKD) disrupts renal parenchyma through progressive expansion of fluid‐filled cysts. The only approved pharmacotherapy for ADKPD involves the blockade of the vasopressin type 2 receptor (V2R).
Externí odkaz:
https://doaj.org/article/074bf8c607b8486189284e5954cd8661
Autor:
Francesco P. Schena, Giovanni Pertosa
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 13, Iss Suppl. 2 (2001)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/7ed32ed8ee10460dbd72b3e9f440dd71
Publikováno v:
Kidney International Reports, Vol 5, Iss 10, Pp 1627-1629 (2020)
Externí odkaz:
https://doaj.org/article/968ff9d35fb54f4591503923185a3f3a
Publikováno v:
Clinical Kidney Journal. 15:1028-1028
Background Randomized controlled trials (RCTs) have been conducted, stratifying idiopathic immunoglobulin A nephropathy (IgAN) patients based on the laboratory findings [serum creatinine, estimated glomerular filtration rate (eGFR) and daily proteinu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63dceb2a6602ffbf94a15b793be2c1c2
https://doi.org/10.1093/ckj/sfac063
https://doi.org/10.1093/ckj/sfac063
Autor:
Gianluigi Zaza, Simona Granata, Valentina Masola, Carlo Rugiu, Francesco Fantin, Loreto Gesualdo, Francesco Paolo Schena, Antonio Lupo
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77847 (2013)
Mitochondria, essential eukaryotic cells organelles defined as the "powerhouse of the cell" because of their ability to produce the vast majority of energy necessary for cellular metabolism, may have a primary role in the oxidative stress-related int
Externí odkaz:
https://doaj.org/article/b261c9ead44243e39c28d085a42a9a3b
Autor:
Fabio Sallustio, Grazia Serino, Vincenzo Costantino, Claudia Curci, Sharon N Cox, Giuseppe De Palma, Francesco P Schena
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68296 (2013)
Adult renal progenitor cells (ARPCs) were recently identified in the cortex of the renal parenchyma and it was demonstrated that they were positive for PAX2, CD133, CD24 and exhibited multipotent differentiation ability. Recent studies on stem cells
Externí odkaz:
https://doaj.org/article/d8f9dc23536d4054bf109eeb2b137750
Autor:
Rosa Ragone, Fabio Sallustio, Sara Piccinonna, Monica Rutigliano, Galleggiante Vanessa, Silvano Palazzo, Giuseppe Lucarelli, Pasquale Ditonno, Michele Battaglia, Francesco Paolo Fanizzi, Francesco Paolo Schena
Publikováno v:
Diseases, Vol 4, Iss 1, p 7 (2016)
Renal cell carcinoma (RCC) is a heterogeneous cancer often showing late symptoms. Until now, some candidate protein markers have been proposed for its diagnosis. Metabolomics approaches have been applied, predominantly using Mass Spectrometry (MS), w
Externí odkaz:
https://doaj.org/article/f919ff0807874a588ae4834a3db17f6d
Autor:
Francesco P, Schena, Michael D, Pascoe, Josefina, Alberu, Maria, del Carmen Rial, Rainer, Oberbauer, Daniel C, Brennan, Josep M, Campistol, Lorraine, Racusen, Martin S, Polinsky, Robert, Goldberg-Alberts, Huihua, Li, Joseph, Scarola, John F, Neylan, M, Zand
Publikováno v:
Transplantation
Background. The efficacy and safety of converting maintenance renal transplant recipients from calcineurin inhibitors (CNIs) to sirolimus (SRL) was evaluated. Methods. Eight hundred thirty renal allograft recipients, 6 to 120 months posttransplant an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57cc4f10cb4ecdf56f77cb69f996a4f
https://doi.org/10.1097/tp.0b013e3181927a41
https://doi.org/10.1097/tp.0b013e3181927a41
Autor:
Fabio Sallustio, Grazia Serino, Vincenzo Costantino, Claudia Curci, Sharon N. Cox, Giuseppe De Palma, Francesco P. Schena
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 5, p e0128258 (2015)
PLoS ONE, Vol 10, Iss 5, p e0128258 (2015)
Adult renal progenitor cells (ARPCs) were recently identified in the cortex of the renal parenchyma and it was demonstrated that they were positive for PAX2, CD133, CD24 and exhibited multipotent differentiation ability. Recent studies on stem cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af0d129dbde37ba59722a45e7ca87cb
http://europepmc.org/articles/PMC4425473
http://europepmc.org/articles/PMC4425473